designed and developed 68 Ga- and 18F- labeled molecular tracers targeting the FAP and αvβ3 dual-specific heterodimer FAPI-RGD, demonstrating its superiority over mono targets in human pancreatic cancer tumor-bearing mouse model. This evidence concerns the gene FAP and familial pancreatic carcinoma.